ArticleCureus2025
Intramuscular Promethazine Added to IV Ondansetron for the Prevention of Intrathecal Morphine-Induced Pruritus and Nausea After Cesarean Delivery: A Randomized Controlled Trial.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Intrathecal morphine is commonly used to facilitate postoperative pain control after cesarean delivery (CD). However, pruritus, nausea, and vomiting are frequent medication-related side effects. We hypothesized that adding prophylactic intramuscular promethazine (IMP) would reduce intrathecal morphine-related pruritus and other side effects more effectively than standard care with ondansetron alone. In this single-center, double-blinded, randomized controlled trial of patients undergoing scheduled CD under spinal anesthesia with intrathecal morphine, all participants received standard care with prophylactic IV ondansetron prior to surgery and were randomly assigned to receive either IMP 25 mg or intramuscular saline placebo after umbilical cord clamping. Pruritus, nausea and vomiting, agitation, fatigue, and pain were assessed at one hour, four hours, and 24 hours postoperatively. Secondary outcomes included pain, the Sedation-Agitation Scale, and fatigue. Sixty-seven patients completed the protocol: 34 received IMP, and 33 received intramuscular saline placebo. Among the total population, 15% reported nausea or vomiting, and 63% reported pruritus. No differences were observed between patients receiving prophylactic IMP and those receiving saline placebo regarding pruritus, nausea, vomiting, agitation, fatigue, or pain at any time point. The addition of prophylactic IMP to standard care with prophylactic IV ondansetron did not reduce the incidence of intrathecal morphine-induced side effects after scheduled CD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.